Policy Archives – Page 2 of 4 – Treatment Action Group

After Cuomo Speech, NY Health Orgs Including TAG Warn that Governor’s Health Plan Falls Short

January 9, 2020
Dorrit Walsh

TAG, as part of the Save NY Public Health Campaign, called out Governor Cuomo's recently announced Medicaid cuts and other failures to adequately address health and health equity in his January 8, 2020 "State of the State" address.

Treatment Action Group Applauds Progress on Ending HIV in New York, Cautions Against Complacency

December 4, 2019
Dorrit Walsh

Treatment Action Group (TAG) applauds progress in New York towards ending HIV as an epidemic, with record decreases in estimated statewide and citywide HIV incidence in 2018. TAG states that accelerating impact at the community level will be critical to reach the Ending the Epidemic 2020 targets.

TAG Stands with Safehouse and Opposes Dangerous Policies That Jeopardize Access to Lifesaving Harm Reduction Services

December 3, 2019
Dorrit Walsh

In honor of World AIDS Day, Treatment Action Group (TAG) continues to stand with the global harm reduction movement in support of evidence based, live saving interventions for people who use drugs, including syringe service programs and safer consumption spaces (SCS).

TAG Comment in Response to Proposed Rulemaking: Visas: Ineligibility Based on Public Charge Grounds

October 30, 2019
Dorrit Walsh

As an organization dedicated to ensuring equitable access to critical health services to individuals and communities affected by HIV/AIDS, tuberculosis (TB), and hepatitis C virus (HCV), Treatment Action Group (TAG) strongly opposes the proposed changes regarding “public charge,” published in the Federal Register on October 11, 2019 (the proposed rule).

Statement: Truly Corrective Actions on Drug Pricing Will Bring Life-Saving Benefit to Consumers in the U.S. and Globally

October 16, 2019
Dorrit Walsh

This is a joint statement from TAG and Health GAP October 16, 2019 – Although Speaker Nancy Pelosi’s bill to increase affordable access to medicines in the U.S., H.R. 3, offers halting, partial steps to reduce drug prices for some…

ANEA Response to Guardian Article on Gov. Rick Scott’s Rejection of $70 Million in Federal Funding to Fight Florida’s HIV/AIDS Crisis

September 18, 2019
Dorrit Walsh

The Act Now End AIDS coalition is deeply troubled by the contents of Ben Ryan’s September 11 Guardian article “'Rick Scott had us on lockdown:' how Florida said no to $70m for HIV crisis." The article, which reflects four years of investigative journalism by Ryan with additional reporting by Noah Pransky, paints a detailed picture of how Florida’s then-governor, Rick Scott, refused Medicaid expansion and federal dollars to fight the epidemic from 2015-2017

Ensuring Treatment for Children with Orphan Diseases: Ending Exemptions from the Pediatric Research Equity Act (PREA)

August 27, 2019
Chad Cipiti

August 27, 2019 – This policy brief was developed by TAG and the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), and it details how children with TB are affected by the pediatric research exemption for orphan drugs. The brief also proposes…

Pharma Lies, People Die: Myth-Busting Fact Sheet on Medicine Development and Pricing

December 10, 2018
Chad Cipiti

By Bryn Gay, HCV Project Director, TAG and Claudine Guerra, CUNY DOWNLOAD to print this article as a poster (A1 size) The current leaders of the United States manufacture crises, media optics, and catchy sound bites to side step actual…

Getting Rid of the Boogeyman: The Reality of Prescription Drug Price Controls

December 10, 2018
Chad Cipiti

By Annette Gaudino, HCV/HIV Project Co-Director, TAG Do you remember how old you were when you stopped believing in the monster under your bed? How many times did you have to look and see nothing there before you finally believed…

Fierce Activism from the Global Access to Medicines (A2M) Movement: Reflections on Recent Sucess

December 7, 2018
Chad Cipiti

By Bryn Gay, HCV Project Director, TAG Access to medicines (A2M) activists have become better coordinated, articulate, and adept in responding to pharmaceutical industry shenanigans that threaten access to affordable medicines since the establishment of harmonized global intellectual property (IP) …